How computer vision can improve defect detection and traceability in pharma inspection

By the engineering team at Lantern Med Digital (LMD)

Pharmaceutical manufacturing depends on repeatable inspection. A tablet with a crack, chip, stain, discoloration or other visible anomaly can signal a problem that deserves attention before product moves further downstream. Human inspection remains valuable, but it is inherently variable and difficult to scale consistently across long runs, multiple products and changing operators.

Computer vision offers a practical way to add another layer of monitoring. This article explains how an inspection system moves from controlled image capture to on-device inference and traceable results, and what engineering choices matter when the goal is not an AI demonstration, but a system that could fit into an actual manufacturing workflow. The perspective comes from LMD’s hands-on prototyping work with tablet-defect inspection and pharmaceutical label verification using compact edge hardware, cameras, controlled lighting and recorded production-like video.

1. The quality imperative in 2026 pharmaceutical manufacturing

The quality challenge is broader than catching an obviously broken tablet. Visual inspection can also help surface subtler changes such as stains, discoloration, shape irregularities, print or embossing issues and packaging or labeling inconsistencies. In a regulated environment, the value of automation is not simply speed: it is the ability to apply the same inspection logic repeatedly and to retain evidence of what the system saw and how it classified it.

That makes computer vision especially relevant as a monitoring and traceability layer. A well-designed system can complement existing quality processes by creating image-based records, flagging suspect units for review and providing structured data that can later be correlated with batches, equipment states or process changes. The design objective should be reliable evidence and consistent decision support, not automation for its own sake.

A useful way to frame the investment is not as ‘adding AI,’ but as adding another repeatable observation point to the quality process. In the prototypes built by LMD, that meant starting from a narrow inspection question and designing the smallest camera, lighting, compute and software stack that could answer it reliably. This keeps early development focused on operational value rather than technology for its own sake.

2. Why computer vision now? The 2026 technology landscape

Vision systems are becoming easier to deploy because useful inference no longer requires a large centralized computing stack. Compact edge devices can sit close to the camera, process images locally and return results without depending on a continuous cloud connection. Cameras, lighting, embedded compute and software can therefore be packaged as a small inspection station that is easier to prototype and integrate into an existing line or test cell.

That compact architecture is particularly important for pilots. The tablet and label-verification demos were built around edge processing close to the image source, demonstrating that inspection logic can be packaged with the camera and lighting instead of requiring a separate server environment. For manufacturers, that creates a lower-friction path to test monitoring at one process step before committing to broader line integration.

3. How automated tablet inspection works: From image to insight

Step 1: Tablet presentation

In production, tablets must be presented in a repeatable way so the camera sees comparable views. Depending on the process, this can mean guided conveyors, feeders, fixtures or other mechanisms that control position and orientation. For prototyping, recorded or staged material can be used to validate the vision pipeline before mechanical integration begins.

Step 2: Image acquisition

The camera and lighting establish the quality ceiling of the entire system. Controlled illumination helps reduce glare, shadows and background variation so visible defects such as cracks, stains, discoloration or edge damage are easier to distinguish from normal appearance. In LMD’s tablet demos, the emphasis was on building a simple, repeatable capture setup around a camera and dedicated light source rather than assuming the model could compensate for inconsistent images.

Steps 3-6: Processing, classification, rejection and logging

After capture, software isolates the region of interest and applies a vision model or rule-based checks to identify anomalies. The output can include pass/fail status, defect type, confidence and the source image. On an edge device, that decision can be produced locally and then forwarded to a user interface, a quality record or a downstream control system. The same pattern can be extended from tablets to packaging, where the inspection target becomes a label, lot number, printed field or other visual identifier.

Hands-on prototyping also reinforces a recurring engineering lesson: image acquisition comes first. In the tablet work, cracks, breaks, stains and discoloration became much easier to reason about once the camera position and illumination were controlled. The model is only as dependable as the visual evidence delivered to it, so time spent on optics and repeatability often pays back more than immediate model tuning.

4. The defect universe: What computer vision systems can detect

For visible tablet inspection, useful defect classes include cracks, chips, broken edges, stains, discoloration, shape inconsistencies, coating anomalies, surface contamination and printing or embossing problems. Which defects can be detected reliably depends on the product, the camera view, lighting, optical resolution and the examples available during development. A prototype should therefore begin with a clearly defined defect set rather than a generic promise to detect anything abnormal.

Defect Category	Visual Signal	Imaging Considerations	Typical Interpretation	Prototype Priority
Cracks / fractures	Linear break or separation	Sharp focus; controlled contrast	Mechanical or handling anomaly	High
Chips / broken edges	Missing material at perimeter	Clear silhouette and edge lighting	Handling or compression issue	High
Stains / discoloration	Localized or distributed color change	Stable white balance; even illumination	Possible contamination or process variation	High
Shape inconsistencies	Contour or dimension change	Consistent orientation and scale	Tooling or forming variation	Medium
Coating anomalies	Texture, gloss, color or coverage change	Lighting selected for the coating finish	Coating-process variation	Medium
Surface contamination	Foreign spot or material	Resolution matched to target feature	Environmental or material issue	High
Print / embossing issues	Missing, shifted or malformed marking	Front-facing view; contrast control	Identification or tooling issue	Medium

The tablet demo focused on defects that are visually meaningful and straightforward to communicate to an operator: broken areas, cracks, stains and discoloration. That scope matters. A focused set of observable failure modes makes it easier to collect examples, evaluate errors and explain what the system can and cannot detect before expanding to more subtle classes.

5. Image acquisition strategies: Lighting, cameras and optics

Lighting is one of the highest-leverage design choices in a vision system. Bright, even illumination can simplify color and shape inspection, while directional or dark-field arrangements can make edges and surface texture more visible. Diffuse lighting can reduce reflections on glossy packaging. The right choice depends on the actual defect or printed feature being inspected, so lighting should be evaluated with representative samples rather than selected from a generic recipe.

Camera and lens selection should follow the same principle: start from the smallest feature that matters and the physical area that must be visible in each frame. The objective is not to maximize specification sheets, but to obtain repeatable images with enough detail for the intended decision. This is particularly important for compact, low-cost systems, where careful optical design can avoid unnecessary compute and camera expense.

Technique	Best For	Limitations	Integration Impact	Complexity
Bright-field	Color, shape, dark marks	Can hide texture on reflective surfaces	Simple illumination and enclosure	Low
Dark-field / directional	Edges, scratches, surface texture	Less useful for uniform color measurement	Requires controlled light angle	Medium
Diffuse illumination	Labels, color, reflective packaging	May reduce contrast for fine texture	Useful when glare is a concern	Low-Medium
Structured light	Height or surface-topography cues	Adds calibration and processing	More specialized optical setup	High
Multispectral	Signals outside normal visible imaging	More hardware and calibration	Use only when visible light is insufficient	High
Multi-view imaging	More complete surface coverage	Requires camera synchronization or motion control	Higher mechanical and compute integration	High

The same principle appeared in the packaging prototype. When the target changed from a tablet surface to a bottle label, the core architecture remained familiar – camera, illumination, edge processing and software – but the imaging problem changed. Glare, text legibility, label position, lot information and field placement became the important variables. Reusing the architecture while redesigning the capture conditions is a practical way to move quickly between inspection tasks.

6. Classification models powering modern inspection systems

Model choice should follow the inspection problem and the available data. Conventional computer vision can be effective for geometry, alignment, contrast or text-region checks. Convolutional networks and modern object-detection or classification models are useful when the appearance varies more significantly. Anomaly-detection approaches can also be attractive when examples of good product are plentiful but real defect samples are scarce. In practice, hybrid pipelines are often more useful than choosing a single algorithm for every inspection task.

For early-stage systems, model architecture should remain a means rather than the product. The LMD prototypes were designed to support experimentation with the inspection pipeline while keeping the deployment footprint small. That makes it possible to compare conventional vision, OCR, detection, classification or anomaly-based methods against the same captured data and choose what best fits the use case.

7. Explainability: Building trust in AI-driven quality decisions

For quality applications, a pass/fail result is more useful when it is accompanied by evidence. Saving the source image, the detected region, the predicted class and relevant metadata creates a record that a human can review. This also helps teams understand false positives, investigate borderline cases and improve the system over time. Explainability in this context is as much about operational traceability as it is about model interpretation.

Traceability becomes more tangible when the system preserves what it saw. A rejected frame, detected region, label crop, lot-number read or defect annotation can be stored with the decision and timestamp. Even before a full production integration, this demonstrates how computer vision can create a reviewable record rather than an unexplainable binary output.

8. Validation and regulatory compliance for vision systems

A prototype can demonstrate technical feasibility, but a production deployment in pharmaceutical manufacturing requires a separate validation effort. Requirements must define what is being inspected, under what operating conditions, and what constitutes an acceptable result. Qualification and validation activities then need to show that the complete system – camera, lighting, software, model, interfaces, and operating procedure – behaves consistently within that intended use.

The defect and reference-image library is therefore a core project asset. Teams need representative examples of acceptable product and the defects they actually care about, with labels that can be defended. For AI-enabled systems, change control, versioning, test sets, and ongoing performance review are as important as the initial model training. These activities should be planned from the beginning rather than added after a prototype appears to work.

The gap between a working demo and a validated manufacturing system should be explicit. LMD’s prototypes were built with hardware and simulated or recorded video to prove the inspection concept; they were not represented as validated production deployments. The next stage would require representative line conditions, formal requirements, controlled datasets, integration testing, and the customer’s quality and regulatory validation process.

9. Implementation roadmap: From pilot to production

Phase 1 – Define the inspection target: Identify the visible defects or fields that matter, collect representative samples or video, and agree on what a useful detection looks like.

Phase 2 – Build a focused prototype: Combine the camera, lighting, edge hardware, and initial software into a small test station. Use real or production-like material to determine whether the visual signal is strong enough and whether the model can separate meaningful defects from normal variation.

Phase 3 – Integrate with the workflow: Connect results to the operator interface, local storage, quality system or control layer that needs them. At this stage, latency, reliability, enclosure design, connectivity, and failure handling become as important as model accuracy.

Phase 4 – Validate for intended use: Establish acceptance criteria, challenge the system under realistic operating conditions, document performance, and control software and model versions. A demo becomes a manufacturing tool only after this discipline is applied.

Phase 5 – Improve from operational data: Retained images and inspection results can support error analysis, model refinement, process monitoring, and future defect classes. This is where the system can evolve from a simple gate into a source of quality data.

A practical rollout can therefore stay intentionally incremental. Start with one inspection point and a compact edge station, prove that the images and detections are useful, connect the results to the workflow, and only then harden and validate the system. This approach keeps the first investment smaller while generating the evidence needed to decide whether broader deployment is justified.

10. FAQ: Automated tablet inspection with computer vision

What is computer vision defect detection in pharmaceutical manufacturing?

Computer vision defect detection uses cameras, controlled lighting, and software models to inspect pharmaceutical products or packaging for visible anomalies. Depending on the use case, it can augment manual inspection by applying repeatable checks and retaining image-based evidence for review and traceability.

What defects can computer vision detect in tablets?

Depending on the imaging setup and training data, systems can be designed to detect visible cracks, chips, broken areas, stains, discoloration, shape deviations, coating anomalies, surface contamination, and printing or embossing issues. In packaging applications, the same architecture can be adapted to verify labels, lot numbers, and other printed information.

How fast can automated tablet inspection systems run?

Throughput depends on the camera, exposure time, model complexity, edge hardware, and the mechanics that present each item to the camera. For many projects, image presentation and lighting become the practical constraints before inference speed does. Throughput should therefore be measured on the actual line or representative motion rather than inferred from a model benchmark alone.

What’s the typical false reject rate?

There is no meaningful universal false-reject rate. It depends on the product, defect definition, operating conditions, threshold settings, and quality of the training and validation data. A useful pilot reports its own confusion matrix and error modes on representative samples instead of borrowing a benchmark from another system.

How long does validation take?

Validation time depends on intended use, risk, integration scope, available evidence, and the organization’s quality process. The important planning lesson is to treat validation requirements, traceability, data collection, and version control as design inputs from the beginning rather than as documentation work that starts after the engineering prototype is finished.

What’s the total cost of ownership?

Cost varies widely with optics, mechanics, line integration, validation, and the number of inspection points. A compact edge architecture can reduce infrastructure requirements and make focused pilots comparatively inexpensive, especially when the first goal is to add monitoring at a specific high-value step. The business case should be built around the cost of the inspection problem, the value of additional traceability, and the effort required to integrate and maintain the system.

11. Conclusion: The future of quality assurance in pharma

Computer vision is most useful in pharmaceutical manufacturing when it is treated as an engineering system rather than an isolated AI model. Reliable inspection comes from the combination of controlled imaging, fit-for-purpose algorithms, edge or local compute, workflow integration, and traceable outputs. That combination can support both product inspection and packaging verification while remaining compact enough to prototype quickly.

For manufacturers exploring the technology, a focused feasibility study can be a better first step than a large automation program. Choose one visible problem, build the capture environment around it, test with representative material, and prove that the system produces evidence the quality team can actually use. From there, the same architecture can be hardened, validated, and expanded where the operational value justifies it.

The larger opportunity is the data trail created by inspection. A low-cost vision station can do more than flag an individual tablet or label: over time, retained images and structured results can reveal recurring defect patterns, shifts in appearance or labeling inconsistencies. That turns a local inspection point into a source of process visibility and makes traceability one of the strongest reasons to consider the technology.

About the contributor

Lantern Med Digital (LMD) develops software and embedded systems for medical and life-sciences applications.